Pavlina Jimbei

Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study

Gilbert Habib, Paola Anna Erba, Bernard Iung et al. · European Heart Journal · 2019 · 867 citations · Full text

Medicine, Infectious Diseases, Radiology +15

Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial

Michel Bazinet, Victor Pântea, Valentin Cebotarescu et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 249 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +11

Safety and Efficacy of 48 Weeks REP 2139 or REP 2165, Tenofovir Disoproxil, and Pegylated Interferon Alfa-2a in Patients With Chronic HBV Infection Naïve to Nucleos(t)ide Therapy

Michel Bazinet, Victor Pântea, Gheorghe Plăcintă et al. · Gastroenterology · 2020 · 232 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Persistent Control of Hepatitis B Virus and Hepatitis Delta Virus Infection Following REP 2139-Ca and Pegylated Interferon Therapy in Chronic Hepatitis B Virus/Hepatitis Delta Virus Coinfection

Michel Bazinet, Victor Pântea, Valentin Cebotarescu et al. · Hepatology Communications · 2020 · 84 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

The ESC-EORP EURO-ENDO (European Infective Endocarditis) registry

Gilbert Habib, Patrizio Lancellotti, P.A. Erba et al. · European Heart Journal - Quality of Care and Clinical Outcomes · 2019 · 78 citations · Full text

Medicine, Cardiology, Infectious Diseases +13